<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02506634</url>
  </required_header>
  <id_info>
    <org_study_id>ESR-14-10521</org_study_id>
    <nct_id>NCT02506634</nct_id>
  </id_info>
  <brief_title>The Primary Symptoms of GERD(Gastroesophageal Reflux Disease) in Chinese Outpatients in Gastroenterology Department</brief_title>
  <official_title>The Primary Symptoms of GERD in Chinese Outpatients in Gastroenterology Department: A Cross-sectional Investigation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>First Affiliated Hospital, Sun Yat-Sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>First Affiliated Hospital, Sun Yat-Sen University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Consecutive patients aged 18-65 years who go to the gastroenterology clinic presented with
      upper gastrointestinal discomfort would be included. All patients underwent upper endoscopy
      or an ambulatory 24-h pH(Potential Of Hydrogen) monitoring.Pathologic esophageal acid reflux
      was defined as the percentage total time for which a pH value &lt; 4 was &gt;4.2 % in the distal
      esophagus. Then, patients were treated with esomeprazole 20 mg twice daily for 28 days. The
      symptom scores were measured by the frequency score multiplied by the severity scores of the
      predominant symptom before and at the end of the treatment, and the &quot; PPI test &quot; was defined
      as positive if the overall scores of the predominant dyspeptic symptom in the fourth week
      decreased by &gt;50 % compared with those of the baseline.

      GERD is defined by either 24-hour impedance-pH monitoring or positive PPI(proton pump
      inhibitor) test or positive result from endoscopy. The percentage of each symptom of GERD in
      the symptom questionnaire in Chinese outpatients in Gastroenterology department will be
      calculated. The symptom of the highest percentage will be the primary symptom.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary Objective：To define the primary symptom of GERD in Chinese outpatients in
      Gastroenterology department Secondary Objective：1. To investigate the symptom distribution of
      patients who present with symptoms originated from upper gastrointestinal tract and have
      pathologic esophageal reflux established by 24-hour impedance-pH monitoring, upper endoscopy,
      or proton pump inhibitor test.

      2. To evaluate the life quality of patients with atypical GERD symptoms (symptoms except
      heartburning and regurgitation) 3. To investigate the diagnostic value of proton pump
      inhibitor trial to diagnose GERD with atypical reflux symptoms 4. To investigate the
      predictive value of Gerd Q to diagnose GERD with atypical reflux symptoms with heartburn or
      regurgitation
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2015</start_date>
  <completion_date type="Actual">January 2019</completion_date>
  <primary_completion_date type="Actual">January 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The Primary Symptom of GERD in Chinese Outpatients in Gastroenterology Department</measure>
    <time_frame>over 3 years</time_frame>
    <description>GERD can be diagnosed by more than one different criteria (i.e.&quot;reflux esophagitis on endoscopy&quot;; &quot;positive acid exposure time (AET) on reflux monitoring&quot;;&quot;Either reflux esophagitis on endoscopy or positive AET on reflux monitoring&quot;) in a single participant. When different criteria was used to diagnose GERD, the percentage of GERD patients with different predominant symptom will be calculated. The symptom of the highest percentage will be the primary symptom.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The Percentage of Participants Diagnosed With Reflux Esophagitis Using Endoscopy Among Participants With Different Main Baseline Symptoms</measure>
    <time_frame>over 3 years</time_frame>
    <description>The percentage of paticipants diagnosed with reflux esophagitis on endoscopy among patients with different main symptom in the symptom questionnaire in Chinese outpatients in Gastroenterology department will be calculated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Percentage of Participants Diagnosed With Pathological Acid Reflux Using Reflux Monitoring Among Participants With Different Main Baseline Symptoms</measure>
    <time_frame>over 3 years</time_frame>
    <description>The percentage of paticipants diagnosed with pathological acid reflux using reflux monitoring among patients with different main baseline symptom in the symptom questionnaire in Chinese outpatients in Gastroenterology department will be calculated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Life Quality of GERD Patients Who Were Diagnosed by Either Reflux Esophagitis on Endoscopy or Positive Acid Exposure Time(AET) on Reflux Monitoring and Presented With Different Main Baseline Symptoms</measure>
    <time_frame>over 3 years</time_frame>
    <description>The life quality of GERD patients with different main symptoms before PPI test will be measured via the MOS 36-item short form health survey (SF-36), in which higher scores mean a better quality of life. Its maximum score is 796.5, and the minimum score is 36.5.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Sensitivity of PPI Test for Diagnosis of GERD</measure>
    <time_frame>over 3 years</time_frame>
    <description>The sensitivity of PPI test for the diagnosis of GERD in patients with typical or atypical reflux symptoms will be calculated. The presence of reflux esophagitis on upper endoscopy and/or pathological acid reflux on 24-hour pH monitoring are considered as the &quot;gold standard&quot; for the diagnosis of GERD.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Specificity of PPI Test for Diagnosis of GERD</measure>
    <time_frame>over 3 years</time_frame>
    <description>The specificity of PPI test for the diagnosis of GERD in patients with typical or atypical reflux symptoms will be calculated. The presence of reflux esophagitis on upper endoscopy and/or pathological acid reflux on 24-hour pH monitoring are considered as the &quot;gold standard&quot; for the diagnosis of GERD.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Sensitivity of GERDQ for Diagnosis of GERD</measure>
    <time_frame>over 3 years</time_frame>
    <description>The sensitivity of GERDQ for the diagnosis of GERD in patients with typical or atypical reflux symptoms will be calculated. The presence of reflux esophagitis on upper endoscopy and/or pathological acid reflux on 24-hour pH monitoring are considered as the &quot;gold standard&quot; for the diagnosis of GERD.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Specificity of GERDQ for Diagnosis of GERD</measure>
    <time_frame>over 3 years</time_frame>
    <description>The specificity of GERDQ for the diagnosis of GERD in patients with typical or atypical reflux symptoms will be calculated. The presence of reflux esophagitis on upper endoscopy and/or pathological acid reflux on 24-hour pH monitoring are considered as the &quot;gold standard&quot; for the diagnosis of GERD.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">374</enrollment>
  <condition>Gastroesophageal Reflux</condition>
  <arm_group>
    <arm_group_label>Participants with upper gastrointestinal symptoms</arm_group_label>
    <description>Participants are stratified at baseline based on their main upper gastrointestinal symptoms and then evaluated for GERD using different methods (i.e., reflux esophagitis on endoscopy or positive acid exposure time (AET) on reflux monitoring). Patients would then be given Esomeprazole MUPS（ Multiple Unit Pellet System）20 mg bid for evaluating the ability of the PPI Test for GERD. According to the guidelines, the duraion of PPI treatment was 4 weeks and 8 weeks for endoscopy negative patients and patients has reflux esophagitis, respectively.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Esomeprazole MUPS, 20 mg</intervention_name>
    <description>According to the guidelines, the PPI treatment duration would be 8 weeks(Esomeprazole MUPS, 20 mg bid) for patients with reflux esophagitis and 4 weeks (Esomeprazole MUPS, 20 mg bid) for patients with normal findings on endoscopy.</description>
    <arm_group_label>Participants with upper gastrointestinal symptoms</arm_group_label>
    <other_name>Nexium</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study will be done in the outpatient clinic, department of Gastroenterology, first
        affiliated hospital, sun yet-sen university. Consecutive patients who met the inclusion
        criteria in the Gastroenterology clinic in the first affiliated hospital will be enrolled
        in the study. There will not be any randomization in the study.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Consecutive patients aged 18-65 years who go to the gastroenterology clinic presented
             with upper gastrointestinal discomfort, such as heartburn, regurgitation, dysphagia,
             substernal pain, epigastric pain, epigastric burning, early satiety, postprandial
             fullness.

          -  Whose previous symptoms should last for at least 3 months and be at least 3 days per
             week in frequency with moderate severity.

          -  Able to fill in the questionaires.

        Exclusion Criteria:

          -  gastric or duodenal ulcers, upper GI neoplasms on upper endoscopy

          -  severe cardiac or pulmonary diseases, diabetes or rheumatic diseases

          -  history of operations in the upper GI tract

          -  renal failure or abnormal liver function

          -  use of non-steroidal anti-inflammatory drugs (NSAIDs)

          -  allergy to esomeprazole

          -  Pregnancy or lactating mother
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Minhu Chen, PHD</last_name>
    <role>Study Director</role>
    <affiliation>vice-president of the first Affiliated hospital of SYSU</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>the first affiliated hospital of SYSU</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510080</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>July 20, 2015</study_first_submitted>
  <study_first_submitted_qc>July 21, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 23, 2015</study_first_posted>
  <results_first_submitted>August 8, 2019</results_first_submitted>
  <results_first_submitted_qc>November 10, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">December 4, 2019</results_first_posted>
  <last_update_submitted>December 29, 2019</last_update_submitted>
  <last_update_submitted_qc>December 29, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>First Affiliated Hospital, Sun Yat-Sen University</investigator_affiliation>
    <investigator_full_name>tanniandi</investigator_full_name>
    <investigator_title>Resident physician</investigator_title>
  </responsible_party>
  <keyword>symptom</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastroesophageal Reflux</mesh_term>
    <mesh_term>Esophagitis, Peptic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Esomeprazole</mesh_term>
  </intervention_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>June 8, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/34/NCT02506634/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Four hundred consecutive patients with upper gastrointestinal (GI) symptoms were screened, 19 patients who didn’t meet the inclusion criteria and 7 patients with major motility disorders on high resolution manometry were excluded. Thus, a total of 374 patients were finally enrolled in the current study.</recruitment_details>
      <pre_assignment_details>The current study was a single Arm study where all participants with upper GI symptoms were enrolled and tested for gastro-esophageal reflux disease (GERD) via endoscopy and 24-hour reflux monitoring. Participants were then given proton pump inhibitor(PPI) treatment and the course was decided base on the endoscopy findings.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Patients With Upper GI Symptoms</title>
          <description>Participants were stratified at baseline based on their main gastrointestinal symptoms and then evaluated for GERD using different methods. They also recieved PPI treatment (Esomeprazole MUPS, 20 mg, bid, 4 or 8 weeks) and finished GERDQ.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="374"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Participants Who Were Diagnosed as GERD</title>
              <participants_list>
                <participants group_id="P1" count="154"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Participants Who Received PPI Treatment</title>
              <participants_list>
                <participants group_id="P1" count="357"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Participants Who Finished GERDQ</title>
              <participants_list>
                <participants group_id="P1" count="342"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="357"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>The aim of the current study was to investigate the symptom spectrum of GERD, and patients presented with upper GI symptoms including heartburn, regurgitation, chest pain, dysphagia, epigastric pain, epigastric burning, early satiety and postprandial fullness were enrolled. Baseline analysis population was based on patients' predominant symptom.</population>
      <group_list>
        <group group_id="B1">
          <title>Patients With Predominant Heartburn</title>
          <description>Patients with predominant heartburn were evaluated for GERD using different methods (i.e., reflux esophagitis on endoscopy or positive acid exposure time (AET) on reflux monitoring). They also recieved PPI test and finished GERDQ.</description>
        </group>
        <group group_id="B2">
          <title>Patients With Predominant Regurgitation</title>
          <description>Patients with predominant regurgitation were evaluated for GERD using different methods (i.e., reflux esophagitis on endoscopy or positive acid exposure time (AET) on reflux monitoring). They also recieved PPI test and finished GERDQ.</description>
        </group>
        <group group_id="B3">
          <title>Patients With Predominant Chest Pain</title>
          <description>Patients with predominant chest pain were evaluated for GERD using different methods (i.e., reflux esophagitis on endoscopy or positive acid exposure time (AET) on reflux monitoring). They also recieved PPI test and finished GERDQ.</description>
        </group>
        <group group_id="B4">
          <title>Patients With Predominant Dysphagia</title>
          <description>Patients with predominant dysphagia were evaluated for GERD using different methods (i.e., reflux esophagitis on endoscopy or positive acid exposure time (AET) on reflux monitoring). They also recieved PPI test and finished GERDQ.</description>
        </group>
        <group group_id="B5">
          <title>Patients With Predominant Epigastric Pain</title>
          <description>Patients with predominant epigastric pain were evaluated for GERD using different methods (i.e., reflux esophagitis on endoscopy or positive acid exposure time (AET) on reflux monitoring). They also recieved PPI test and finished GERDQ.</description>
        </group>
        <group group_id="B6">
          <title>Patients With Predominant Epigastric Burning</title>
          <description>Patients with predominant epigastric burning were evaluated for GERD using different methods (i.e., reflux esophagitis on endoscopy or positive acid exposure time (AET) on reflux monitoring). They also recieved PPI test and finished GERDQ.</description>
        </group>
        <group group_id="B7">
          <title>Patients With Predominant Postprandial Fullness</title>
          <description>Patients with predominant postprandial fullness were evaluated for GERD using different methods (i.e., reflux esophagitis on endoscopy or positive acid exposure time (AET) on reflux monitoring). They also recieved PPI test and finished GERDQ.</description>
        </group>
        <group group_id="B8">
          <title>Patients With Predominant Early Satiety</title>
          <description>Patients with predominant early satiety were evaluated for GERD using different methods (i.e., reflux esophagitis on endoscopy or positive acid exposure time (AET) on reflux monitoring). They also recieved PPI test and finished GERDQ.</description>
        </group>
        <group group_id="B9">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="87"/>
            <count group_id="B2" value="82"/>
            <count group_id="B3" value="63"/>
            <count group_id="B4" value="12"/>
            <count group_id="B5" value="35"/>
            <count group_id="B6" value="29"/>
            <count group_id="B7" value="64"/>
            <count group_id="B8" value="2"/>
            <count group_id="B9" value="374"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="87"/>
                    <count group_id="B2" value="82"/>
                    <count group_id="B3" value="63"/>
                    <count group_id="B4" value="12"/>
                    <count group_id="B5" value="35"/>
                    <count group_id="B6" value="29"/>
                    <count group_id="B7" value="64"/>
                    <count group_id="B8" value="2"/>
                    <count group_id="B9" value="374"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="46.90" spread="12.25"/>
                    <measurement group_id="B2" value="40.96" spread="14.06"/>
                    <measurement group_id="B3" value="43.27" spread="10.70"/>
                    <measurement group_id="B4" value="41.83" spread="13.29"/>
                    <measurement group_id="B5" value="42.54" spread="14.56"/>
                    <measurement group_id="B6" value="43.83" spread="14.34"/>
                    <measurement group_id="B7" value="39.88" spread="13.31"/>
                    <measurement group_id="B8" value="30.50" spread="12.02"/>
                    <measurement group_id="B9" value="42.88" spread="12.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="87"/>
                    <count group_id="B2" value="82"/>
                    <count group_id="B3" value="63"/>
                    <count group_id="B4" value="12"/>
                    <count group_id="B5" value="35"/>
                    <count group_id="B6" value="29"/>
                    <count group_id="B7" value="64"/>
                    <count group_id="B8" value="2"/>
                    <count group_id="B9" value="374"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="42"/>
                    <measurement group_id="B2" value="40"/>
                    <measurement group_id="B3" value="32"/>
                    <measurement group_id="B4" value="7"/>
                    <measurement group_id="B5" value="24"/>
                    <measurement group_id="B6" value="18"/>
                    <measurement group_id="B7" value="31"/>
                    <measurement group_id="B8" value="2"/>
                    <measurement group_id="B9" value="196"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="45"/>
                    <measurement group_id="B2" value="42"/>
                    <measurement group_id="B3" value="31"/>
                    <measurement group_id="B4" value="5"/>
                    <measurement group_id="B5" value="11"/>
                    <measurement group_id="B6" value="11"/>
                    <measurement group_id="B7" value="33"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="178"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                    <count group_id="B4" value="0"/>
                    <count group_id="B5" value="0"/>
                    <count group_id="B6" value="0"/>
                    <count group_id="B7" value="0"/>
                    <count group_id="B8" value="0"/>
                    <count group_id="B9" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B9" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index (BMI)</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="87"/>
                    <count group_id="B2" value="82"/>
                    <count group_id="B3" value="63"/>
                    <count group_id="B4" value="12"/>
                    <count group_id="B5" value="35"/>
                    <count group_id="B6" value="29"/>
                    <count group_id="B7" value="64"/>
                    <count group_id="B8" value="2"/>
                    <count group_id="B9" value="374"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22.22" spread="3.21"/>
                    <measurement group_id="B2" value="22.07" spread="3.17"/>
                    <measurement group_id="B3" value="22.69" spread="3.42"/>
                    <measurement group_id="B4" value="21.20" spread="3.22"/>
                    <measurement group_id="B5" value="21.95" spread="3.31"/>
                    <measurement group_id="B6" value="22.78" spread="3.05"/>
                    <measurement group_id="B7" value="21.39" spread="2.81"/>
                    <measurement group_id="B8" value="17.98" spread="1.12"/>
                    <measurement group_id="B9" value="22.09" spread="3.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>The Primary Symptom of GERD in Chinese Outpatients in Gastroenterology Department</title>
        <description>GERD can be diagnosed by more than one different criteria (i.e.&quot;reflux esophagitis on endoscopy&quot;; &quot;positive acid exposure time (AET) on reflux monitoring&quot;;&quot;Either reflux esophagitis on endoscopy or positive AET on reflux monitoring&quot;) in a single participant. When different criteria was used to diagnose GERD, the percentage of GERD patients with different predominant symptom will be calculated. The symptom of the highest percentage will be the primary symptom.</description>
        <time_frame>over 3 years</time_frame>
        <population>GERD is diagnosed based on different criteria among 374 enrolled patients, and then the percentage of GERD patients with different predominant symptom will be calculated. The symptom of the highest percentage will be the primary symptom.</population>
        <group_list>
          <group group_id="O1">
            <title>GERD Patients Defined by Reflux Esophagitis on Endoscopy</title>
            <description>The percentage of GERD patients with different predominant symptom will be calculated.</description>
          </group>
          <group group_id="O2">
            <title>GERD Patients Defined by Positive AET on Reflux Monitoring</title>
            <description>The percentage of GERD patients with different predominant symptom will be calculated.</description>
          </group>
          <group group_id="O3">
            <title>GERD Patients Defined by Either Endoscopy or Reflux Monitoring</title>
            <description>The percentage of GERD patients with different predominant symptom will be calculated.</description>
          </group>
        </group_list>
        <measure>
          <title>The Primary Symptom of GERD in Chinese Outpatients in Gastroenterology Department</title>
          <description>GERD can be diagnosed by more than one different criteria (i.e.&quot;reflux esophagitis on endoscopy&quot;; &quot;positive acid exposure time (AET) on reflux monitoring&quot;;&quot;Either reflux esophagitis on endoscopy or positive AET on reflux monitoring&quot;) in a single participant. When different criteria was used to diagnose GERD, the percentage of GERD patients with different predominant symptom will be calculated. The symptom of the highest percentage will be the primary symptom.</description>
          <population>GERD is diagnosed based on different criteria among 374 enrolled patients, and then the percentage of GERD patients with different predominant symptom will be calculated. The symptom of the highest percentage will be the primary symptom.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="79"/>
                <count group_id="O2" value="111"/>
                <count group_id="O3" value="154"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Heartburn</title>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                    <measurement group_id="O2" value="30"/>
                    <measurement group_id="O3" value="42"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Regurgitation</title>
                  <measurement_list>
                    <measurement group_id="O1" value="23"/>
                    <measurement group_id="O2" value="30"/>
                    <measurement group_id="O3" value="38"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Chest pain</title>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="16"/>
                    <measurement group_id="O3" value="23"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Dysphagia</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Epigastric pain</title>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="11"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Epigastric burning</title>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="13"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Postprandial fullness</title>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="23"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Early satiety</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Percentage of Participants Diagnosed With Reflux Esophagitis Using Endoscopy Among Participants With Different Main Baseline Symptoms</title>
        <description>The percentage of paticipants diagnosed with reflux esophagitis on endoscopy among patients with different main symptom in the symptom questionnaire in Chinese outpatients in Gastroenterology department will be calculated.</description>
        <time_frame>over 3 years</time_frame>
        <population>Among 374 enrolled patients presented with different main symptom, the percentage of patients with reflux esophagitis was calculated.</population>
        <group_list>
          <group group_id="O1">
            <title>Patients With Predominant Heartburn</title>
            <description>The percentage of paticipants diagnosed with reflux esophagitis on endoscopy among patients with predominant heartburn will be calculated.</description>
          </group>
          <group group_id="O2">
            <title>Patients With Predominant Regurgitation</title>
            <description>The percentage of paticipants diagnosed with reflux esophagitis on endoscopy among patients with predominant regurgitation will be calculated.</description>
          </group>
          <group group_id="O3">
            <title>Patients With Predominant Chest Pain</title>
            <description>The percentage of paticipants diagnosed with reflux esophagitis on endoscopy among patients with predominant chest pain will be calculated.</description>
          </group>
          <group group_id="O4">
            <title>Patients With Predominant Dysphagia</title>
            <description>The percentage of paticipants diagnosed with reflux esophagitis on endoscopy among patients with predominant dysphagia will be calculated.</description>
          </group>
          <group group_id="O5">
            <title>Patients With Predominant Epigastric Pain</title>
            <description>The percentage of paticipants diagnosed with reflux esophagitis on endoscopy among patients with predominant epigastric pain will be calculated.</description>
          </group>
          <group group_id="O6">
            <title>Patients With Predominant Epigastric Burning</title>
            <description>The percentage of paticipants diagnosed with reflux esophagitis on endoscopy among patients with predominant epigastric burning will be calculated.</description>
          </group>
          <group group_id="O7">
            <title>Patients With Predominant Postprandial Fullness</title>
            <description>The percentage of paticipants diagnosed with reflux esophagitis on endoscopy among patients with predominant postprandial fullness will be calculated.</description>
          </group>
          <group group_id="O8">
            <title>Patients With Predominant Early Satiety</title>
            <description>The percentage of paticipants diagnosed with reflux esophagitis on endoscopy among patients with predominant early satiety will be calculated.</description>
          </group>
        </group_list>
        <measure>
          <title>The Percentage of Participants Diagnosed With Reflux Esophagitis Using Endoscopy Among Participants With Different Main Baseline Symptoms</title>
          <description>The percentage of paticipants diagnosed with reflux esophagitis on endoscopy among patients with different main symptom in the symptom questionnaire in Chinese outpatients in Gastroenterology department will be calculated.</description>
          <population>Among 374 enrolled patients presented with different main symptom, the percentage of patients with reflux esophagitis was calculated.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="87"/>
                <count group_id="O2" value="82"/>
                <count group_id="O3" value="63"/>
                <count group_id="O4" value="12"/>
                <count group_id="O5" value="35"/>
                <count group_id="O6" value="29"/>
                <count group_id="O7" value="64"/>
                <count group_id="O8" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                    <measurement group_id="O2" value="23"/>
                    <measurement group_id="O3" value="9"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="9"/>
                    <measurement group_id="O6" value="4"/>
                    <measurement group_id="O7" value="13"/>
                    <measurement group_id="O8" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Percentage of Participants Diagnosed With Pathological Acid Reflux Using Reflux Monitoring Among Participants With Different Main Baseline Symptoms</title>
        <description>The percentage of paticipants diagnosed with pathological acid reflux using reflux monitoring among patients with different main baseline symptom in the symptom questionnaire in Chinese outpatients in Gastroenterology department will be calculated.</description>
        <time_frame>over 3 years</time_frame>
        <population>Among 374 enrolled patients presented with different main symptom, the percentage of patients with pathological acid reflux was calculated.</population>
        <group_list>
          <group group_id="O1">
            <title>Patients With Predominant Heartburn</title>
            <description>The percentage of paticipants diagnosed with pathological acid reflux using reflux monitoring among patients with predominant heartburn will be calculated.</description>
          </group>
          <group group_id="O2">
            <title>Patients With Predominant Regurgitation</title>
            <description>The percentage of paticipants diagnosed with pathological acid reflux using reflux monitoring among patients with predominant regurgitation will be calculated.</description>
          </group>
          <group group_id="O3">
            <title>Patients With Predominant Chest Pain</title>
            <description>The percentage of paticipants diagnosed with pathological acid reflux using reflux monitoring among patients with predominant chest pain will be calculated.</description>
          </group>
          <group group_id="O4">
            <title>Patients With Predominant Dysphagia</title>
            <description>The percentage of paticipants diagnosed with pathological acid reflux using reflux monitoring among patients with predominant dysphagia will be calculated.</description>
          </group>
          <group group_id="O5">
            <title>Patients With Predominant Epigastric Pain</title>
            <description>The percentage of paticipants diagnosed with pathological acid reflux using reflux monitoring among patients with predominant epigastric pain will be calculated.</description>
          </group>
          <group group_id="O6">
            <title>Patients With Predominant Epigastric Burning</title>
            <description>The percentage of paticipants diagnosed with pathological acid reflux using reflux monitoring among patients with predominant epigastric burning will be calculated.</description>
          </group>
          <group group_id="O7">
            <title>Patients With Predominant Postprandial Fullness</title>
            <description>The percentage of paticipants diagnosed with pathological acid reflux using reflux monitoring among patients with predominant postprandial fullness will be calculated.</description>
          </group>
          <group group_id="O8">
            <title>Patients With Predominant Early Satiety</title>
            <description>The percentage of paticipants diagnosed with pathological acid reflux using reflux monitoring among patients with predominant early satiety will be calculated.</description>
          </group>
        </group_list>
        <measure>
          <title>The Percentage of Participants Diagnosed With Pathological Acid Reflux Using Reflux Monitoring Among Participants With Different Main Baseline Symptoms</title>
          <description>The percentage of paticipants diagnosed with pathological acid reflux using reflux monitoring among patients with different main baseline symptom in the symptom questionnaire in Chinese outpatients in Gastroenterology department will be calculated.</description>
          <population>Among 374 enrolled patients presented with different main symptom, the percentage of patients with pathological acid reflux was calculated.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="87"/>
                <count group_id="O2" value="82"/>
                <count group_id="O3" value="63"/>
                <count group_id="O4" value="12"/>
                <count group_id="O5" value="35"/>
                <count group_id="O6" value="29"/>
                <count group_id="O7" value="64"/>
                <count group_id="O8" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30"/>
                    <measurement group_id="O2" value="30"/>
                    <measurement group_id="O3" value="16"/>
                    <measurement group_id="O4" value="4"/>
                    <measurement group_id="O5" value="5"/>
                    <measurement group_id="O6" value="11"/>
                    <measurement group_id="O7" value="15"/>
                    <measurement group_id="O8" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Life Quality of GERD Patients Who Were Diagnosed by Either Reflux Esophagitis on Endoscopy or Positive Acid Exposure Time(AET) on Reflux Monitoring and Presented With Different Main Baseline Symptoms</title>
        <description>The life quality of GERD patients with different main symptoms before PPI test will be measured via the MOS 36-item short form health survey (SF-36), in which higher scores mean a better quality of life. Its maximum score is 796.5, and the minimum score is 36.5.</description>
        <time_frame>over 3 years</time_frame>
        <population>The analysis population for this outcome measure was patients with a GERD diagnosis by either reflux esophagitis on upper endoscopy or positive acid exposure time(AET) on reflux monitoring.</population>
        <group_list>
          <group group_id="O1">
            <title>GERD Patients With Predominant Heartburn</title>
            <description>The life quality of GERD patients with predominant heartburn will be measured via the MOS 36-item short form health survey (SF-36).</description>
          </group>
          <group group_id="O2">
            <title>GERD Patients With Predominant Regurgitation</title>
            <description>The life quality of GERD patients with predominant regurgitation will be measured via the MOS 36-item short form health survey (SF-36).</description>
          </group>
          <group group_id="O3">
            <title>GERD Patients With Predominant Chest Pain</title>
            <description>The life quality of GERD patients with predominant chest pain will be measured via the MOS 36-item short form health survey (SF-36).</description>
          </group>
          <group group_id="O4">
            <title>GERD Patients With Predominant Dysphagia</title>
            <description>The life quality of GERD patients with predominant dysphagia will be measured via the MOS 36-item short form health survey (SF-36).</description>
          </group>
          <group group_id="O5">
            <title>GERD Patients With Predominant Epigastric Pain</title>
            <description>The life quality of GERD patients with predominant epigastric pain will be measured via the MOS 36-item short form health survey (SF-36).</description>
          </group>
          <group group_id="O6">
            <title>GERD Patients With Predominant Epigastric Burning</title>
            <description>The life quality of GERD patients with predominant epigastric burning will be measured via the MOS 36-item short form health survey (SF-36).</description>
          </group>
          <group group_id="O7">
            <title>GERD Patients With Predominant Postprandial Fullness</title>
            <description>The life quality of GERD patients with predominant postprandial fullness will be measured via the MOS 36-item short form health survey (SF-36).</description>
          </group>
          <group group_id="O8">
            <title>GERD Patients With Predominant Early Satiety</title>
            <description>The life quality of GERD patients with predominant early satiety will be measured via the MOS 36-item short form health survey (SF-36).</description>
          </group>
        </group_list>
        <measure>
          <title>The Life Quality of GERD Patients Who Were Diagnosed by Either Reflux Esophagitis on Endoscopy or Positive Acid Exposure Time(AET) on Reflux Monitoring and Presented With Different Main Baseline Symptoms</title>
          <description>The life quality of GERD patients with different main symptoms before PPI test will be measured via the MOS 36-item short form health survey (SF-36), in which higher scores mean a better quality of life. Its maximum score is 796.5, and the minimum score is 36.5.</description>
          <population>The analysis population for this outcome measure was patients with a GERD diagnosis by either reflux esophagitis on upper endoscopy or positive acid exposure time(AET) on reflux monitoring.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="38"/>
                <count group_id="O3" value="23"/>
                <count group_id="O4" value="4"/>
                <count group_id="O5" value="11"/>
                <count group_id="O6" value="13"/>
                <count group_id="O7" value="23"/>
                <count group_id="O8" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="565.04" spread="163.59"/>
                    <measurement group_id="O2" value="582.55" spread="128.87"/>
                    <measurement group_id="O3" value="606.35" spread="134.44"/>
                    <measurement group_id="O4" value="706.67" spread="18.35"/>
                    <measurement group_id="O5" value="581.15" spread="193.52"/>
                    <measurement group_id="O6" value="545.8" spread="176.79"/>
                    <measurement group_id="O7" value="618.18" spread="152.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Sensitivity of PPI Test for Diagnosis of GERD</title>
        <description>The sensitivity of PPI test for the diagnosis of GERD in patients with typical or atypical reflux symptoms will be calculated. The presence of reflux esophagitis on upper endoscopy and/or pathological acid reflux on 24-hour pH monitoring are considered as the &quot;gold standard&quot; for the diagnosis of GERD.</description>
        <time_frame>over 3 years</time_frame>
        <population>This outcome measure is the sensitivity of PPI test for GERD diagnosis, so the whole analysis population would be patients who finished PPI treatment. Note: typical reflux symptoms are heartburn and regurgitation; atypical reflux symptoms are chest pain, dysphagia, epigastric pain, epigastric burning, postprandial fullness, and early satiety.</population>
        <group_list>
          <group group_id="O1">
            <title>Patients With Typical Reflux Symptoms</title>
            <description>The sensitivity of PPI test for the diagnosis of GERD in patients with typical reflux symptoms will be calculated.</description>
          </group>
          <group group_id="O2">
            <title>Patients With Atypical Symptoms</title>
            <description>The sensitivity of PPI test for the diagnosis of GERD in patients with atypical reflux symptoms will be calculated.</description>
          </group>
        </group_list>
        <measure>
          <title>The Sensitivity of PPI Test for Diagnosis of GERD</title>
          <description>The sensitivity of PPI test for the diagnosis of GERD in patients with typical or atypical reflux symptoms will be calculated. The presence of reflux esophagitis on upper endoscopy and/or pathological acid reflux on 24-hour pH monitoring are considered as the &quot;gold standard&quot; for the diagnosis of GERD.</description>
          <population>This outcome measure is the sensitivity of PPI test for GERD diagnosis, so the whole analysis population would be patients who finished PPI treatment. Note: typical reflux symptoms are heartburn and regurgitation; atypical reflux symptoms are chest pain, dysphagia, epigastric pain, epigastric burning, postprandial fullness, and early satiety.</population>
          <units>Percentage of true positive</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="160"/>
                <count group_id="O2" value="197"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.64"/>
                    <measurement group_id="O2" value="0.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Specificity of PPI Test for Diagnosis of GERD</title>
        <description>The specificity of PPI test for the diagnosis of GERD in patients with typical or atypical reflux symptoms will be calculated. The presence of reflux esophagitis on upper endoscopy and/or pathological acid reflux on 24-hour pH monitoring are considered as the &quot;gold standard&quot; for the diagnosis of GERD.</description>
        <time_frame>over 3 years</time_frame>
        <population>This outcome measure is the specificity of PPI test for GERD diagnosis, so the whole analysis population would be patients who finished PPI treatment. Note: typical reflux symptoms are heartburn and regurgitation; atypical reflux symptoms are chest pain, dysphagia, epigastric pain, epigastric burning, postprandial fullness, and early satiety.</population>
        <group_list>
          <group group_id="O1">
            <title>Patients With Typical Reflux Symptoms</title>
            <description>The specificity of PPI test for the diagnosis of GERD in patients with typical reflux symptoms will be calculated.</description>
          </group>
          <group group_id="O2">
            <title>Patients With Atypical Symptoms</title>
            <description>The specificity of PPI test for the diagnosis of GERD in patients with atypical reflux symptoms will be calculated.</description>
          </group>
        </group_list>
        <measure>
          <title>The Specificity of PPI Test for Diagnosis of GERD</title>
          <description>The specificity of PPI test for the diagnosis of GERD in patients with typical or atypical reflux symptoms will be calculated. The presence of reflux esophagitis on upper endoscopy and/or pathological acid reflux on 24-hour pH monitoring are considered as the &quot;gold standard&quot; for the diagnosis of GERD.</description>
          <population>This outcome measure is the specificity of PPI test for GERD diagnosis, so the whole analysis population would be patients who finished PPI treatment. Note: typical reflux symptoms are heartburn and regurgitation; atypical reflux symptoms are chest pain, dysphagia, epigastric pain, epigastric burning, postprandial fullness, and early satiety.</population>
          <units>Percentage of true negative</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="160"/>
                <count group_id="O2" value="197"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.40"/>
                    <measurement group_id="O2" value="0.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Sensitivity of GERDQ for Diagnosis of GERD</title>
        <description>The sensitivity of GERDQ for the diagnosis of GERD in patients with typical or atypical reflux symptoms will be calculated. The presence of reflux esophagitis on upper endoscopy and/or pathological acid reflux on 24-hour pH monitoring are considered as the &quot;gold standard&quot; for the diagnosis of GERD.</description>
        <time_frame>over 3 years</time_frame>
        <population>This outcome measure is the sensitivity of GERDQ for GERD diagnosis, so the whole analysis population would be patients who finished GERDQ. Note: typical reflux symptoms are heartburn and regurgitation; atypical reflux symptoms are chest pain, dysphagia, epigastric pain, epigastric burning, postprandial fullness, and early satiety.</population>
        <group_list>
          <group group_id="O1">
            <title>Patients With Typical Reflux Symptoms</title>
            <description>The sensitivity of GERDQ for the diagnosis of GERD in patients with typical reflux symptoms will be calculated.</description>
          </group>
          <group group_id="O2">
            <title>Patients With Atypical Symptoms</title>
            <description>The sensitivity of GERDQ for the diagnosis of GERD in patients with atypical reflux symptoms will be calculated.</description>
          </group>
        </group_list>
        <measure>
          <title>The Sensitivity of GERDQ for Diagnosis of GERD</title>
          <description>The sensitivity of GERDQ for the diagnosis of GERD in patients with typical or atypical reflux symptoms will be calculated. The presence of reflux esophagitis on upper endoscopy and/or pathological acid reflux on 24-hour pH monitoring are considered as the &quot;gold standard&quot; for the diagnosis of GERD.</description>
          <population>This outcome measure is the sensitivity of GERDQ for GERD diagnosis, so the whole analysis population would be patients who finished GERDQ. Note: typical reflux symptoms are heartburn and regurgitation; atypical reflux symptoms are chest pain, dysphagia, epigastric pain, epigastric burning, postprandial fullness, and early satiety.</population>
          <units>Percentage of true positive</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="153"/>
                <count group_id="O2" value="189"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.84"/>
                    <measurement group_id="O2" value="0.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Specificity of GERDQ for Diagnosis of GERD</title>
        <description>The specificity of GERDQ for the diagnosis of GERD in patients with typical or atypical reflux symptoms will be calculated. The presence of reflux esophagitis on upper endoscopy and/or pathological acid reflux on 24-hour pH monitoring are considered as the &quot;gold standard&quot; for the diagnosis of GERD.</description>
        <time_frame>over 3 years</time_frame>
        <population>This outcome measure is the specificity of GERDQ for GERD diagnosis, so the whole analysis population would be patients who finished GERDQ. Note: typical reflux symptoms are heartburn and regurgitation; atypical reflux symptoms are chest pain, dysphagia, epigastric pain, epigastric burning, postprandial fullness, and early satiety.</population>
        <group_list>
          <group group_id="O1">
            <title>Patients With Typical Reflux Symptoms</title>
            <description>The specificity of GERDQ for the diagnosis of GERD in patients with typical reflux symptoms will be calculated.</description>
          </group>
          <group group_id="O2">
            <title>Patients With Atypical Symptoms</title>
            <description>The specificity of GERDQ for the diagnosis of GERD in patients with atypical reflux symptoms will be calculated.</description>
          </group>
        </group_list>
        <measure>
          <title>The Specificity of GERDQ for Diagnosis of GERD</title>
          <description>The specificity of GERDQ for the diagnosis of GERD in patients with typical or atypical reflux symptoms will be calculated. The presence of reflux esophagitis on upper endoscopy and/or pathological acid reflux on 24-hour pH monitoring are considered as the &quot;gold standard&quot; for the diagnosis of GERD.</description>
          <population>This outcome measure is the specificity of GERDQ for GERD diagnosis, so the whole analysis population would be patients who finished GERDQ. Note: typical reflux symptoms are heartburn and regurgitation; atypical reflux symptoms are chest pain, dysphagia, epigastric pain, epigastric burning, postprandial fullness, and early satiety.</population>
          <units>Percentage of true negative</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="153"/>
                <count group_id="O2" value="189"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.24"/>
                    <measurement group_id="O2" value="0.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>over 3 years</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Patients Who Received PPI Treatment</title>
          <description>The frequency of adverse events among patients who received PPI treatment was calculated.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <description>There was one serious adverse event (SAE) that a patient had pneumothorax during the treatment phase and withdrew from the study, which had no causality with any drug or study procedure.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="42" subjects_at_risk="357"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Abdominal distension</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Diarrhea</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Bitter taste</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="357"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="357"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Niandi Tan</name_or_title>
      <organization>FirstSunYetSen</organization>
      <phone>+86 15989117039</phone>
      <email>tanniandi@126.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

